Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On point, yet again. I don't know why people are so hostile toward you. You give a bone on a golden platter, and they bite the hand that feeds them!
Haha :D
Women ruin everything :D
What if you have money AND cocaine??
Don't count Aphria out either :P
Aphria Appears Headed to the New York Stock Exchange:
https://www.newcannabisventures.com/aphria-appears-headed-to-the-new-york-stock-exchange/
Canopy to cannabis as McDonalds to fast food.
Cooper is CIA~
Demand has been awesome, and predicted. Pictures of lines around buildings, and stores selling out~
I was smoking a joint outside at midnight last night, hoping to make some new friends, but I was all alone :(
lol
HAPPY CANNABIS DAY!!!!!!!!!!
They are pardoning simple possession, you will be able to go golfing there again!!!
Once the clock hits midnight tonight, in 8 hours!
I will cease being a criminal in 8 hours!
15 and 30min charts are gearing up, it looks like.
What price did you short at??
Holy cow
Thanks!
HAPPY FINAL TUESDAY, AND FINAL DAY BEFORE CANNABIS DAY!!!!!!!!!!
LET'S MAKE SOME MAAANNIEEEEEEEEEEEEEEEE
Aphria Commends UK Government on Medical Cannabis Legalization, Forms Alliance With Noted Neurologist and Leading Cannabis Advocate Professor Michael Barnes
Canada NewsWire
LEAMINGTON, ON, Oct. 16, 2018
The Company and Professor Barnes will collaborate on clinical trials to advance the applications of medical cannabis
LEAMINGTON, ON, Oct. 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) commends the Government of the United Kingdom for its decision last week to legalize medical cannabis. The Company is pleased to also announce that is has formed an alliance with noted UK-based neurologist and rehabilitation physician Professor Michael Barnes MD FRCP, a leading voice on medical cannabis policy in Europe.
Aphria (CNW Group/Aphria Inc.)
"I applaud the UK government for taking this step to legalize medical cannabis," said Vic Neufeld, Chief Executive Officer of Aphria. "It's great news for patients in need across the UK and represents another major milestone in the advancement of medical cannabis around the world. We are also thrilled to join forces with Professor Barnes, among the world's most respected and influential advocates for medical cannabis."
Professor Barnes is a celebrated authority on neurological rehabilitation in the UK and internationally. He has a long-standing interest and expertise in the use of cannabinoids for the management of spasticity and in other neurological conditions. He was involved with the development of GW Pharma's Sativex and provided the final expert independent opinion to the UK government prior to license approval. His review of cannabis medical indications for the all-party parliamentary group on drug reform was highly influential in the UK Government's decision to legalize cannabis for medicinal purposes.
"This is a tremendous moment for medical cannabis in the UK and its momentum towards continued acceptance and application around the world," said Professor Barnes. "I have long been interested in the medical applications of cannabis, and I look forward to a fruitful collaboration with Aphria, one of the leading global cannabis companies, to further the exploration of medical cannabis through clinical examination."
Professor Barnes is an honorary professor of neurological rehabilitation at the University of Newcastle, Founder President of the World Federation of Neurological Rehabilitation and Past President of the British Society of Rehabilitation Medicine. He has also served as chief executive of NHS organizations.
Aphria and Professor Barnes are collaborating on clinical studies of patients in the UK and Canada to advance the understanding of the application of medical cannabis to certain conditions and disease states.
We Have A Good Thing Growing
There's no need for that. He hasn't posted. No need to be a dick.
There's no need to explain yourself to people who think you're "bashing" the stock and making end of days predictions.
For those of us that understand charting and technical analysis, your posts have proven to be on point.
I can't thank you enough, and apologize for the funny guys. It looks like you've been having a fun time here tonight, even though you have no shares :P
Cheers dude. This Corona is for you!
Enjoyed your post :D
Wowsers!!! Awesome!
Yeah...More exposure to the US.
Market seems to like it though....Can we still complain? lol
Aphria completes first shipment of cannabis oil to Argentina for clinical study on treating refractory epilepsy in children
Canada NewsWire
LEAMINGTON, ON, Oct. 15, 2018
Aphria delivers 1,500 bottles of Rideau oil to its subsidiary ABP to support the advancement of clinical medical cannabis research
The Company also completes first shipment of medical cannabis to Malta-based subsidiary ASG Pharma
LEAMINGTON, ON, Oct. 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has completed its first shipment of cannabis oil to its Argentina-based subsidiary ABP, S.A. ("ABP" or the "Argentinean Company"), a pharmaceutical import and distribution company. In accordance with a previously announced supply agreement, the Company delivered 1,500 bottles of Aphria's renowned Rideau CBD oil, which were provided to Hospital de Pediatria Garrahan ("Hospital Garrahan" or the "Hospital"), a leading pediatric hospital located in Buenos Aires, for use in a clinical study focused on treating refractory epilepsy in children.
Aphria Logo (CNW Group/Aphria Inc.)
Aphria acquired ABP last month when the Company closed its acquisition of LATAM Holdings Inc. ("LATAM Holdings"), expanding the Company's global footprint to include a leading presence in Latin America and the Caribbean. "Argentina will play a foundational role as Aphria cements its leadership in medical cannabis throughout the region," said Vic Neufeld, Chief Executive Officer of Aphria. "Aphria and ABP, in close partnership with the Argentinean government, continue to advance opportunities for medical cannabis in the country, including the potential for in-country cultivation. We are also proud to support the critical and necessary research being undertaken by Hospital Garrahan on the treatment of refractory epilepsy in children with our Rideau CBD oil."
As a well-established and successful pharmaceutical import and distribution company, ABP was granted the first permit issued by the Argentina Ministry of Health for the import of pharmaceutical-grade medical cannabis. The Argentinean Company has been forging a reputation as a champion for the research and clinical study of medical cannabis, including through its partnership with the Hospital, one of the most recognized and credible medical institutions in South America.
The clinical study, which involves 100 patients and will be conducted over 2.5 years, will be one of the foundational global scientific and medical studies of its kind focused on treating refractory epilepsy in children. Medical researchers will conduct a pharmacokinetics study of the Rideau product, which will help optimize the ideal dosage in future patients. Top neurologists and pediatric specialists from around the country will participate and, with the support of ABP and Aphria, will receive training and support to be able to train and educate a network of doctors throughout Argentina.
Aphria completes first shipment of medical cannabis to ASG Pharma
The Company also announced it has completed its first shipment of cannabis oil to its Malta-based subsidiary ASG Pharma Ltd. ("ASG"). The majority-owned subsidiary received the first import certificate for medical cannabis issued by the Government of Malta's Ministry of Health and will use this first delivery of Aphria's renowned Rideau CBD oil to perform analytical testing and research.
"This marks another important milestone as we continue to execute on our strategic expansion plans in Europe and around the world," added Neufeld. "Our EU-GMP certified lab in Malta will play an important role for the Company in accessing cannabis markets across the continent, and it will stand as a leading European centre for the research and testing of medical cannabis and derivative products."
ASG's facilities, which are undergoing a multi-million-euro upgrade of its processing and manufacturing capabilities, will serve as Aphria's hub for importing cannabis resin and dried flower for processing, packaging and distribution of EU-GMP certified cannabis products throughout large parts of Europe
We Have A Good Thing Growing
Why more dilution? We have billions of dollars.....
Disappointed with that! But good news, besides more dilution!
HAPPY FINAL PROHIBITION MONDAY!!!!!!!!!!!
The tingly feeling you'll get when you smoke Tweed's product, probably has more to do with the radiation they douse their product with.
I'm sure I'll try something of theirs at some point in time, but doubtfully any time soon.
The last Friday weekend before Canadian legalization!
Corona's for everyone!!!!!!
Could be possible that some companies were ready for that, and could put out some great news and surprise the flippers~
Cheers!
I'm not a beer drinker at all. When I do have a beer, it can't be in a can.
I've had a Corona a day for the last 2 months. I gave up on the limes :D
I don't have the ability to short yet. And, there is absolutely nothing wrong with shorting. I think it's fantastic that there are tools to enable us to make money even when prices are going down.
Is there something wrong with making money when stock prices go down?
I am day trading. Several trades a day. You're not allowed to do that with the TFSA.
Black market favours from the politicians in quebec. Alcohol is 18 there, but 19 almost everywhere else in the country. How does it make any sense to make cannabis 21? lol
It's definitely not what a lot of us expected, that's for sure.
It wasn't enough to fuck us with giving the company away, they had to fuck us when they went public too >>